An all-in-one liquid biopsy service for early cancer detection and risk assessment
Lucence INSIGHT™ is an advanced liquid biopsy test that uses a single blood sample to detect up to 50 different cancers at an early stage. It offers a non-invasive, painless way to assess your risk of cancer, giving you peace of mind over your health through early detection and proactive care.
Discover the key cancer categories and specific cancers that Lucence INSIGHT™ can detect with a single blood test.
Source: LucenceINSIGHT
Lucence INSIGHT™ offers five test options, each detecting a different number of cancers. Whether you want to screen for 5, 12, or a comprehensive range of up to 50 cancers, there are flexible plans tailored to your needs.
Lucence INSIGHT™ 5
Lucence INSIGHT™ 7
Lucence INSIGHT™ 12
Covering 12 types of cancer, in addition to the cancers detectable in Lucence INSIGHT™ 5 and 7.
Lucence INSIGHT™ 50
The most comprehensive option, screening for 50 cancers, including those detectable in Lucence INSIGHT™ 5, 7, and 12. Additional cancer types include:
Covering 12 types of cancer, in addition to the cancers detectable in Lucence INSIGHT™ 5 and 7.
The most comprehensive option, screening for 50 cancers, including those detectable in Lucence INSIGHT™ 5, 7, and 12. Additional cancer types include:
Sensitivity refers to the test’s ability to correctly identify individuals who do have cancer (true positives).
Specificity refers to the test’s ability to correctly identify individuals who do not have cancer (true negatives).
As Lucence INSIGHT™ represents an advanced cancer screening method, this timeline highlights the key stages patients can expect before, during, and after the screening.
Lucence INSIGHT™ is recommended for individuals who want to proactively assess their risk of developing cancer, including:
The screening uses a simple blood test to detect cancer-related genetic changes by analysing circulating tumour DNA (ctDNA) in the bloodstream.
Coverage varies by insurance provider and policy. It’s best to check directly with your insurance company to confirm if Lucence INSIGHT™ cancer screening is included under your plan.
Yes, Lucence INSIGHT™ is designed for early cancer detection and can be taken even if you have no symptoms. It’s a proactive way to monitor your health and detect cancer at an early stage.
The turnaround time for the report is 20 working days after the blood sample is collected. You will receive a comprehensive report outlining any findings and recommended next steps.
Schedule an appointment to discuss your suitability for Lucence INSIGHT™ cancer screenings.
5/F, Century Square, 1 D’Aguilar Street, Central, HK
Mon - Fri: 08:00 – 19:00
Sat: 09:00 – 17:00
Sunday: 09:00 - 13:00
Public Holidays: 09:00 - 13:00
OT&P Healthcare has direct billing arrangements with many international and local insurance companies. We accept many major insurance cards; however, we ask you to check with us for confirmation. For more information, please call us at +852 2155 9055 or email us at business@otandp.com.